iPhone app iPad app Android phone app Android tablet app More

Hadyn Parry

Hadyn Parry

RSS Feed
GET UPDATES FROM Hadyn Parry
 
Hadyn Parry is CEO of Oxitec, a company pioneering a new approach using advanced genetics to combat Dengue fever, other insect-borne diseases and agricultural pests.

Hadyn has an extensive background in the Life Science sector. During his fifteen-year career at Zeneca/Syngenta he held various positions, including General Manager of Zeneca Plant Sciences and European Director and Global Head of R&D for Advanta, one of the world’s
largest seed companies. More recently he was CEO of MNL pharmaceuticals, a company that was focused on pioneering a novel approach in immunology.

He is also Chairman of Help for Heroes, a charity founded in 2007 to support wounded British soldiers.

Blog Entries by Hadyn Parry

The Moment of Truth for British Science

(1) Comments | Posted 2 June 2012 | (00:11)

As the head of a British start-up science business I have found myself deeply concerned by the reaction to the Rothamsted GM wheat trial in Harpenden, Hertfordshire. I quite firmly believe that as a society, and for the British science industry specifically, we have reached a moment of truth.

...
Read Post